Cancer
Cancer biotech Chimeric soars 50pc on debut
Champagne corks are flying for investors in emerging cancer therapy company Chimeric Therapeutics, which had a stellar start to listed life, thanks to …
Champagne corks are flying for investors in emerging cancer therapy company Chimeric Therapeutics, which had a stellar start to listed life, thanks to …
/cloudfront-us-east-2.images.arcpublishing.com/reuters/O2EKP2VIWBMMDGYNGJJDGMFQRQ.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/gray/W6ALM2FXXRABRLH7FPSBFVBAPA.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/tbt/NJLTG34INVDXTB2JDYQBAD3EB4.jpg)
